Risk: benefit ratio is important in treating atopic dermatitis.
Allen
B Roger
BR
Luger
Thomas A
TA
D003876:Dermatitis, Atopic / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D018570:Risk Assessment; D016559:Tacrolimus / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D016559:Tacrolimus